Cleveland Clinic Children's Outcomes
Pediatric Hematology and Oncology
Central Line-Associated Bloodstream Infections
To avoid central line-associated bloodstream infections (CLABSIs), healthcare providers must follow a strict protocol when inserting the line and stringent infection control practices each time they check the line or change the dressing.¹
Non-Mucosal Barrier Central Line-Associated Bloodstream Infections
2016 - 2018
CL = central line, NHSN = National Healthcare Safety Network
ᵃ National Healthcare Safety Network 2016 - 2017 benchmark for central line-associated bloodstream infections (CLABSI) is 2.1/1000 central line days for pediatric Hematology Oncology ward. NHSN no longer uses benchmarks for CLABSI rate.
Non-MBI CLABSI refers to a CLABSI that is not due to a mucosal barrier injury. This distinction is important in hematology/oncology where many of the patients are at risk for mucosal breakdown.